![Dong Zhi Wei](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Dong Zhi Wei
Direttore/Membro del Consiglio presso Chongqing Genrix Biopharmaceutical Co., Ltd.
Relazioni attive
Nome | Sesso | Età | Società collegate | Collaborazione |
---|---|---|---|---|
Chun Sheng Li | M | - |
Chongqing Genrix Biopharmaceutical Co., Ltd.
![]() Chongqing Genrix Biopharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Chongqing Genrix Biopharmaceutical Co., Ltd. principally engages in the research, development, production, and sale of antibody drugs. Its key antibody drugs are mainly for autoimmune diseases, infectious diseases, and tumors. The company was founded on October 20, 2015 and is headquartered in Chongqing, China. | 2 anni |
Ji Kuan Shan | M | 52 |
Chongqing Genrix Biopharmaceutical Co., Ltd.
![]() Chongqing Genrix Biopharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Chongqing Genrix Biopharmaceutical Co., Ltd. principally engages in the research, development, production, and sale of antibody drugs. Its key antibody drugs are mainly for autoimmune diseases, infectious diseases, and tumors. The company was founded on October 20, 2015 and is headquartered in Chongqing, China. | 9 anni |
Yun Tong Hu | M | 42 |
Chongqing Genrix Biopharmaceutical Co., Ltd.
![]() Chongqing Genrix Biopharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Chongqing Genrix Biopharmaceutical Co., Ltd. principally engages in the research, development, production, and sale of antibody drugs. Its key antibody drugs are mainly for autoimmune diseases, infectious diseases, and tumors. The company was founded on October 20, 2015 and is headquartered in Chongqing, China. | 2 anni |
Zhi Yuan Chang | M | 44 |
Chongqing Genrix Biopharmaceutical Co., Ltd.
![]() Chongqing Genrix Biopharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Chongqing Genrix Biopharmaceutical Co., Ltd. principally engages in the research, development, production, and sale of antibody drugs. Its key antibody drugs are mainly for autoimmune diseases, infectious diseases, and tumors. The company was founded on October 20, 2015 and is headquartered in Chongqing, China. | 9 anni |
Zhi Gang Liu | M | 51 |
Chongqing Genrix Biopharmaceutical Co., Ltd.
![]() Chongqing Genrix Biopharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Chongqing Genrix Biopharmaceutical Co., Ltd. principally engages in the research, development, production, and sale of antibody drugs. Its key antibody drugs are mainly for autoimmune diseases, infectious diseases, and tumors. The company was founded on October 20, 2015 and is headquartered in Chongqing, China. | 4 anni |
Li Wen Liu | M | 33 |
Chongqing Genrix Biopharmaceutical Co., Ltd.
![]() Chongqing Genrix Biopharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Chongqing Genrix Biopharmaceutical Co., Ltd. principally engages in the research, development, production, and sale of antibody drugs. Its key antibody drugs are mainly for autoimmune diseases, infectious diseases, and tumors. The company was founded on October 20, 2015 and is headquartered in Chongqing, China. | 3 anni |
Li Chen | M | 47 |
Chongqing Genrix Biopharmaceutical Co., Ltd.
![]() Chongqing Genrix Biopharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Chongqing Genrix Biopharmaceutical Co., Ltd. principally engages in the research, development, production, and sale of antibody drugs. Its key antibody drugs are mainly for autoimmune diseases, infectious diseases, and tumors. The company was founded on October 20, 2015 and is headquartered in Chongqing, China. | 2 anni |
Ren Sheng Jiang | M | 71 |
Chongqing Genrix Biopharmaceutical Co., Ltd.
![]() Chongqing Genrix Biopharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Chongqing Genrix Biopharmaceutical Co., Ltd. principally engages in the research, development, production, and sale of antibody drugs. Its key antibody drugs are mainly for autoimmune diseases, infectious diseases, and tumors. The company was founded on October 20, 2015 and is headquartered in Chongqing, China. | 3 anni |
Jia Qian Yang | F | 42 |
Chongqing Genrix Biopharmaceutical Co., Ltd.
![]() Chongqing Genrix Biopharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Chongqing Genrix Biopharmaceutical Co., Ltd. principally engages in the research, development, production, and sale of antibody drugs. Its key antibody drugs are mainly for autoimmune diseases, infectious diseases, and tumors. The company was founded on October 20, 2015 and is headquartered in Chongqing, China. | 3 anni |
Min Kou | F | 39 |
Chongqing Genrix Biopharmaceutical Co., Ltd.
![]() Chongqing Genrix Biopharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Chongqing Genrix Biopharmaceutical Co., Ltd. principally engages in the research, development, production, and sale of antibody drugs. Its key antibody drugs are mainly for autoimmune diseases, infectious diseases, and tumors. The company was founded on October 20, 2015 and is headquartered in Chongqing, China. | 7 anni |
Hong Fan | F | 36 |
Chongqing Genrix Biopharmaceutical Co., Ltd.
![]() Chongqing Genrix Biopharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Chongqing Genrix Biopharmaceutical Co., Ltd. principally engages in the research, development, production, and sale of antibody drugs. Its key antibody drugs are mainly for autoimmune diseases, infectious diseases, and tumors. The company was founded on October 20, 2015 and is headquartered in Chongqing, China. | 7 anni |
Jun Hua Qian | M | 57 |
Chongqing Genrix Biopharmaceutical Co., Ltd.
![]() Chongqing Genrix Biopharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Chongqing Genrix Biopharmaceutical Co., Ltd. principally engages in the research, development, production, and sale of antibody drugs. Its key antibody drugs are mainly for autoimmune diseases, infectious diseases, and tumors. The company was founded on October 20, 2015 and is headquartered in Chongqing, China. | 3 anni |
Grafico relazionale
Relazione in diverse aziende
Statistiche
Paese | Relazioni | % del totale |
---|---|---|
Cina | 12 | 100.00% |
Età delle relazioni
Attive
Scorse
Uomo
Donna
Amministratori
Dirigenti
Provenienza delle relazioni
- Borsa valori
- Insiders
- Dong Zhi Wei
- Contatti personali